San Francisco, CA
LatchBio develops a data infrastructure intended to build and disseminate the open-source infrastructure of the biocomputing revolution. Founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, the company creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery, thereby enabling biotech companies to find therapies faster and save on engineering.
latch.bioThese are collections LatchBio is a part of. Click on the collection name to view similar companies.
Series A
$28,000,000
Seed
$5,000,000
Pre Seed
$200,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on LatchBio.